CRB-4001

N/A

Report date: 2023/01/07 12:17:28
NME

Base Information

Drug NameCRB-4001
Drug Alias NameJD-5037CRB-4001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCannabinoid CB1 receptor antagonists
TargetsCannabinoid CB1 receptor
Therapy Area/IndicationsObesityInsulin ResistanceDiabetes Mellitus, Type 2 +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCorbus Pharmaceuticals Holdings IncNational Institutes Of Health
China Registration ClassN/A

Develop Information

Active CompaniesCorbus Pharmaceuticals Holdings Inc
Inactive CompaniesN/A
Active IndicationsObesityInsulin ResistanceDiabetes Mellitus, Type 2 +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A